Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niederle

Showing results (401-410 of 490) with videos related to

Pageof 49
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Vasoactive intestinal peptide receptor scintigraphyI Virgolini, A Kurtaran, M Raderer, et al.
Wiener Klinische Wochenschrift|October 30, 1981
[Hyperparathyroidism in chronic renal insufficiency new clinical and surgical aspects (author's transl)]J Kovarik, R Roka, H K Stummvoll, et al.
World Journal of Surgery|July 1, 1994
CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of AustriaF Längle, T Soliman, N Neuhold, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 13, 2012
Bone metabolism in patients with primary hyperparathyroidism before and after surgeryK Kerschan-Schindl, P Riss, C Krestan, et al.
Blood|November 1, 1991
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gammaB Opalka, U B Wandl, R Becher, et al.
European Journal of Haematology|February 1, 1992
A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemiaO Kloke, U Wandl, B Opalka, et al.
Clinical Endocrinology|March 31, 2015
Clinical presentation in insulinoma predicts histopathological tumour characteristicsPeter Wolf, Yvonne Winhofer, Sabina Smajis, et al.
Digital Health|December 17, 2024
Development and testing of a remote hybrid SMS/web-based perioperative messenger: A mixed-methods studyMojca Hriberšek, Daniel Laxar, Fabian Peter Hammerle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinomaM Leimer, A Kurtaran, P Smith-Jones, et al.
Radiology|January 1, 1994
Determination of optimal time window for liver scanning with CT during arterial portographyO Graf, W I Dock, J Lammer, et al.
Pageof 49

Showing results (401-410 of 490) with videos related to

Sort By:
Pageof 49
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Vasoactive intestinal peptide receptor scintigraphyI Virgolini, A Kurtaran, M Raderer, et al.
Wiener Klinische Wochenschrift|October 30, 1981
[Hyperparathyroidism in chronic renal insufficiency new clinical and surgical aspects (author's transl)]J Kovarik, R Roka, H K Stummvoll, et al.
World Journal of Surgery|July 1, 1994
CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of AustriaF Längle, T Soliman, N Neuhold, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 13, 2012
Bone metabolism in patients with primary hyperparathyroidism before and after surgeryK Kerschan-Schindl, P Riss, C Krestan, et al.
Blood|November 1, 1991
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gammaB Opalka, U B Wandl, R Becher, et al.
European Journal of Haematology|February 1, 1992
A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemiaO Kloke, U Wandl, B Opalka, et al.
Clinical Endocrinology|March 31, 2015
Clinical presentation in insulinoma predicts histopathological tumour characteristicsPeter Wolf, Yvonne Winhofer, Sabina Smajis, et al.
Digital Health|December 17, 2024
Development and testing of a remote hybrid SMS/web-based perioperative messenger: A mixed-methods studyMojca Hriberšek, Daniel Laxar, Fabian Peter Hammerle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinomaM Leimer, A Kurtaran, P Smith-Jones, et al.
Radiology|January 1, 1994
Determination of optimal time window for liver scanning with CT during arterial portographyO Graf, W I Dock, J Lammer, et al.
Pageof 49